Commentary
In this review in Japanese, H. Yamamoto et al. (Tokyo University of Agriculture and Technology, Japan) outline the current issues in the diagnosis and treatment of NASH and introduce their research for the discovery of early diagnostic markers and the development of new therapeutic agents using liver organoid cultures derived from mouse models of NASH.
Previous Post
Review: MAFLD prevalence in children and adolescents
Next Post
NAFLD and coronary artery calcium score